# Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)

> **NCT04570722** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer
- Melanoma
- Thoracic Cancer
- Lymphedema of Upper Arm

## Interventions

- **OTHER:** Ipsilateral peripheral IV insertion

## Key facts

- **NCT ID:** NCT04570722
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-20
- **Primary completion:** 2023-01-09
- **Final completion:** 2023-01-09
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04570722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04570722, "Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04570722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*